Oxidative Stress & Cardiovascular Disease

Product name

MDA-oxLDL

Malondialdehyde oxidised low densitiy lipoprotein

Cat-Nr.BI-20022
Range0 – 10 µg/ml
Sensitivity0.3 µg/ml
Incubation time3.5 h
Sample volume20 µl
Sample type

Serum, plasma (Citrate, EDTA or Heparin)

Sample preparation

Centrifuge freshly collected blood as soon as possible.
Aliquoted samples should be stored at -20°C or lower.
Maximum 4 freeze-thaw-cycles.

Species

Human

Tests96
MethodELISA
Intended use

Oxidatively modified lipoproteins (ox-LDLs) play an important role in the progression of atherosclerosis and coronary artery disease. Low-density lipoprotein (LDL), the main carrier of plasma cholesterol, consists of a hydrophobic core and a surface monolayer of polar lipids and Apolipoprotein-B (ApoB). Oxidative stress and the consequent formation of free radicals lead to the peroxidation of ApoB. Malondialdehyde (MDA) has been identifiedas one of the major lipid peroxidation products of LDL, thus playing an important role in the LDL oxidation.
The MDA ox-LDL ELISA specifically detects MDA-modified Apo B in human serum and plasma.

Product informations

Back to overview